CN109776388B - Synthetic method of indoline derivative with C2 quaternary carbon center - Google Patents
Synthetic method of indoline derivative with C2 quaternary carbon center Download PDFInfo
- Publication number
- CN109776388B CN109776388B CN201910223550.2A CN201910223550A CN109776388B CN 109776388 B CN109776388 B CN 109776388B CN 201910223550 A CN201910223550 A CN 201910223550A CN 109776388 B CN109776388 B CN 109776388B
- Authority
- CN
- China
- Prior art keywords
- formula
- preparation
- reaction
- group
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229910052799 carbon Inorganic materials 0.000 title claims abstract description 39
- 125000003387 indolinyl group Chemical class N1(CCC2=CC=CC=C12)* 0.000 title claims abstract 4
- 238000010189 synthetic method Methods 0.000 title description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 41
- 238000006243 chemical reaction Methods 0.000 claims abstract description 40
- 238000002360 preparation method Methods 0.000 claims abstract description 32
- 230000001588 bifunctional effect Effects 0.000 claims abstract description 31
- 125000003118 aryl group Chemical group 0.000 claims description 20
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 19
- 239000002585 base Substances 0.000 claims description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 7
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 7
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 150000002431 hydrogen Chemical class 0.000 claims description 6
- 239000003513 alkali Substances 0.000 claims description 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 125000003609 aryl vinyl group Chemical group 0.000 claims description 4
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 4
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 150000008300 phosphoramidites Chemical class 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- 125000006239 protecting group Chemical group 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 40
- 230000015572 biosynthetic process Effects 0.000 abstract description 38
- 230000007246 mechanism Effects 0.000 abstract description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract description 8
- 238000005580 one pot reaction Methods 0.000 abstract description 6
- 238000003402 intramolecular cyclocondensation reaction Methods 0.000 abstract description 4
- 125000003277 amino group Chemical group 0.000 abstract description 3
- 238000011065 in-situ storage Methods 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 2
- 238000006713 insertion reaction Methods 0.000 abstract description 2
- 150000001408 amides Chemical class 0.000 abstract 1
- 239000000047 product Substances 0.000 description 58
- 239000007787 solid Substances 0.000 description 27
- 238000000034 method Methods 0.000 description 25
- 239000002994 raw material Substances 0.000 description 21
- 150000002476 indolines Chemical class 0.000 description 20
- -1 N-substituted-2-iodoanilines Chemical class 0.000 description 17
- 239000000126 substance Substances 0.000 description 16
- 239000000758 substrate Substances 0.000 description 16
- 230000008569 process Effects 0.000 description 15
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 13
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 11
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 9
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 7
- 125000001424 substituent group Chemical group 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 125000000623 heterocyclic group Chemical group 0.000 description 6
- 230000004071 biological effect Effects 0.000 description 4
- 239000007810 chemical reaction solvent Substances 0.000 description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
- 125000001476 phosphono group Chemical group [H]OP(*)(=O)O[H] 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- FXWFZIRWWNPPOV-UHFFFAOYSA-N 2-aminobenzaldehyde Chemical class NC1=CC=CC=C1C=O FXWFZIRWWNPPOV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 229910052727 yttrium Inorganic materials 0.000 description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 125000006575 electron-withdrawing group Chemical group 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- OEXGDKRAUFQNRI-UHFFFAOYSA-N vallesamidine Chemical compound C1=CC=C2N(C)C3(C45)CCC4(CC)CCCN5CCC3C2=C1 OEXGDKRAUFQNRI-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- KURPPWHPIYBYBS-UHFFFAOYSA-N 2-ethenylaniline Chemical compound NC1=CC=CC=C1C=C KURPPWHPIYBYBS-UHFFFAOYSA-N 0.000 description 1
- 125000001999 4-Methoxybenzoyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C(*)=O 0.000 description 1
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 description 1
- ALZDMJPUQGYCAX-MKMNVTDBSA-N 5-[(E)-(4-hydroxyphenyl)methylideneamino]-3-methyl-7H-[1,2]thiazolo[5,4-d]pyrimidine-4,6-dione Chemical compound Cc1nsc2[nH]c(=O)n(\N=C\c3ccc(O)cc3)c(=O)c12 ALZDMJPUQGYCAX-MKMNVTDBSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100108551 Mus musculus Akr1b7 gene Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GSEZYWGNEACOIW-UHFFFAOYSA-N bis(2-aminophenyl)methanone Chemical class NC1=CC=CC=C1C(=O)C1=CC=CC=C1N GSEZYWGNEACOIW-UHFFFAOYSA-N 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 239000012973 diazabicyclooctane Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- QKLCQKPAECHXCQ-UHFFFAOYSA-N ethyl phenylglyoxylate Chemical compound CCOC(=O)C(=O)C1=CC=CC=C1 QKLCQKPAECHXCQ-UHFFFAOYSA-N 0.000 description 1
- GNNILMDCYQGMRH-UHFFFAOYSA-N formyl benzoate Chemical class O=COC(=O)C1=CC=CC=C1 GNNILMDCYQGMRH-UHFFFAOYSA-N 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- BAEJBRCYKACTAA-WGUOAFTMSA-N mitragynine pseudoindoxyl Chemical group N1C2=CC=CC(OC)=C2C(=O)[C@]21CCN1C[C@@H](CC)[C@@H](\C(=C/OC)C(=O)OC)C[C@H]12 BAEJBRCYKACTAA-WGUOAFTMSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 239000003402 opiate agonist Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 238000010651 palladium-catalyzed cross coupling reaction Methods 0.000 description 1
- FAQJJMHZNSSFSM-UHFFFAOYSA-N phenylglyoxylic acid Chemical compound OC(=O)C(=O)C1=CC=CC=C1 FAQJJMHZNSSFSM-UHFFFAOYSA-N 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
- MECWMLXKVKDFDN-UHFFFAOYSA-N trigonoliimine C Natural products COc1ccc2C3=NCCc4c([nH]c5ccccc45)C3(CCNC=O)Nc2c1 MECWMLXKVKDFDN-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Indole Compounds (AREA)
Abstract
本发明属于化合物合成领域,具体提供了一种具有C2季碳中心的吲哚啉衍生物的制备方法,将具有双官能团化合物、α‑羰基甲酸酯溶于有机溶剂,加入六甲基亚磷酰胺进行反应,随后向反应体系中加入碱,继续反应,得到目的产物。本发明技术为全新的机理,基于原位形成的Kukhtin‑Ramirez加合物与双官能团化合物中极性氨基的插入反应,并采用两步一锅法合成策略发生分子内环化反应,以中等至较高的收率合成了一系列具有C2季碳中心的吲哚啉衍生物。The invention belongs to the field of compound synthesis, and specifically provides a preparation method of an indoline derivative with a C2 quaternary carbon center. The amide is reacted, and then a base is added to the reaction system to continue the reaction to obtain the target product. The technology of the present invention is a brand-new mechanism, based on the insertion reaction of the Kukhtin-Ramirez adduct formed in situ with the polar amino group in the bifunctional compound, and adopts a two-step one-pot synthesis strategy to generate an intramolecular cyclization reaction, with medium to A series of indoline derivatives with C2 quaternary carbon centers were synthesized in high yields.
Description
技术领域technical field
本发明属于有机合成技术领域;具体提供了一类具有C2季碳中心的吲哚啉衍生物的合成方法。The invention belongs to the technical field of organic synthesis, and specifically provides a method for synthesizing a class of indoline derivatives with a C2 quaternary carbon center.
背景技术Background technique
具有C2季碳中心的吲哚啉衍生物作为一类具有特殊结构的吲哚类生物碱,能够用于治疗多种疾病,如抗肿瘤、抗细菌感染等,是非常有用的药效基团。这类化合物通常具有良好的生物和药理活性,如Trigonoliimine C具有潜在的抗HIV病毒的生物活性(J.Am.Chem.Soc.2011,133,10050);Mitragynine pseudoindoxyl在豚鼠回肠和小鼠输精管中表现出很强的阿片激动活性(J.Med.Chem.2002,45,1949);从二叶藤Vallesiadichotoma中分离得到的Vallesamidine具有潜在的抗癌活性(Helv.Chim.Acta.1965,48,391)。利用廉价易得的原料、在温和条件下高效合成含有这类分子骨架的天然产物及其类似物,一直是有机合成化学领域的一个研究重点和热点。Indoline derivatives with a C2 quaternary carbon center, as a class of indole alkaloids with special structures, can be used to treat various diseases, such as anti-tumor, anti-bacterial infection, etc., and are very useful pharmacophore groups. Such compounds usually have good biological and pharmacological activities, such as Trigonoliimine C has potential anti-HIV biological activity (J.Am.Chem.Soc.2011,133,10050); Mitragynine pseudoindoxyl in guinea pig ileum and mouse vas deferens Shows strong opioid agonist activity (J.Med.Chem.2002,45,1949); Vallesamidine isolated from Vallesiadichotoma has potential anticancer activity (Helv.Chim.Acta.1965,48,391). The use of cheap and readily available raw materials to efficiently synthesize natural products and their analogs containing such molecular skeletons under mild conditions has always been a research focus and hotspot in the field of organic synthetic chemistry.
具有C2季碳中心的吲哚啉衍生物具有多样的生物活性和药理作用,与之相关的研究活动以及实际应用的开发,均建立在有效获取该类化合物的基础之上。然而,从动植物以及微生物体内分离提取此类吲哚啉衍生物的方法,不仅周期长、成本高,所获取化合物的量也有限,因此,有关具有C2季碳中心的吲哚啉衍生物的有机合成方法吸引了众多有机化学家的浓厚兴趣,同时也建立了一些有效的合成方法。Indoline derivatives with C2 quaternary carbon centers have diverse biological activities and pharmacological effects, and related research activities and development of practical applications are based on the effective acquisition of such compounds. However, the methods for separating and extracting such indoline derivatives from animals, plants and microorganisms are not only long-term, high-cost, but also limited in the amount of compounds obtained. Organic synthesis methods have attracted the strong interest of many organic chemists, and some effective synthetic methods have also been established.
在已有的报道中,对于具有C2季碳中心的吲哚啉衍生物最常用的合成策略均是通过重氮酸酯作起始物的分子内环化反应实现的。2013年Liang等人报道了钯催化下芳基重氮甲酸酯与N-取代-2-碘苯胺的交叉偶联反应,在CO存在下合成了具有α-季碳中心的吲哚啉衍生物(Chem.Commun.2013,49,561)。In the existing reports, the most commonly used synthetic strategies for indoline derivatives with C2 quaternary carbon centers are all achieved by intramolecular cyclization reactions with diazotium esters as starting materials. In 2013, Liang et al. reported the palladium-catalyzed cross-coupling reaction of aryldiazoformates with N-substituted-2-iodoanilines, and synthesized indoline derivatives with α-quaternary carbon centers in the presence of CO. (Chem. Commun. 2013, 49, 561).
2014年,Hu等人报道了Rh2(OAc)4催化下重氮酸酯与2-氨基苯基酮的重氮分解反应。通过分子内Aldol型反应,酮羰基单元捕获氮叶立德,实现了具有C2季碳中心的吲哚啉衍生物的合成(Chem.Commun.2014,50,951)。In 2014, Hu et al. reported the Rh2(OAc) 4 -catalyzed diazolysis reaction of diazotides with 2 -aminophenyl ketones. The synthesis of indoline derivatives with a C2 quaternary carbon center was achieved through an intramolecular Aldol-type reaction where the ketone carbonyl unit captures nitrogen ylides (Chem. Commun. 2014, 50, 951).
随后,该小组利用Rh(II)/酸共催化的合成策略,从初始原料邻氨基查尔酮出发,分子内捕获氮叶立德完成关环,合成了一系列具有C2季碳中心的吲哚啉衍生(J.Org.Chem.2014,79,8440)。Subsequently, the group utilized Rh(II)/ Acid co-catalyzed synthesis strategy, starting from the initial raw material o-aminochalcone, capturing nitrogen ylide in the molecule to complete the ring closure, and synthesizing a series of indoline derivatives with C2 quaternary carbon center (J.Org.Chem.2014,79 , 8440).
2017年,Anbarasan等人从o-乙烯基苯胺和α-重氮酸酯形成的氮叶立德出发,在钯催化下实现分子内关环,合成了具有α-季碳中心的吲哚啉衍生物(ACS Catal.2017,7,6283)。In 2017, Anbarasan et al. started from the nitrogen ylide formed by o-vinylaniline and α-diazoate, realized intramolecular ring closure under palladium catalysis, and synthesized indoline derivatives with α-quaternary carbon center ( ACS Catal. 2017, 7, 6283).
综合上述,关于具有C2季碳中心的吲哚啉衍生物的合成方法只有少量报道,且这些方法仍然存在以下不足之处:只适用于特定结构的分子、初始原料不易得、需使用危险的重氮化物、底物适用范围有限、需要过渡金属参与等,现有方法仍然不能满足结构多样的具有C2季碳中心的吲哚啉衍生物的合成需要,因此,从简单易得的原料出发,发展构建该类化合物的简便、高效的合成新方法,仍然是有机合成化学中一个重要的课题。To sum up the above, there are only a few reports on the synthetic methods of indoline derivatives with C Nitrogen compounds and substrates have limited scope of application, and transition metals are required. Existing methods still cannot meet the needs for the synthesis of indoline derivatives with C2 quaternary carbon centers with diverse structures. Therefore, starting from simple and readily available raw materials, development It is still an important topic in organic synthetic chemistry to construct a simple and efficient new method for the synthesis of such compounds.
发明内容SUMMARY OF THE INVENTION
本发明的目的是提供一种高效合成具有C2季碳中心的吲哚啉衍生物的新方法。The object of the present invention is to provide a new method for efficiently synthesizing indoline derivatives with C2 quaternary carbon centers.
本发明采用以下的技术方案实现:The present invention adopts the following technical scheme to realize:
一种具有C2季碳中心的吲哚啉衍生物的制备方法,将具有式1结构式的双官能团化合物、式2结构式的α-羰基甲酸酯溶于有机溶剂,加入六甲基亚磷酰胺进行反应,随后向反应体系中加入碱,继续反应至结束,分离得到式3结构的目的产物:A preparation method of an indoline derivative having a C2 quaternary carbon center, the bifunctional compound having the structural formula of formula 1 and the α-carbonyl formate of the structural formula of formula 2 are dissolved in an organic solvent, and hexamethylphosphoramidite is added to carry out Reaction, then in the reaction system, add alkali, continue to react to finish, separate and obtain the purpose product of formula 3 structure:
Ar为芳香性基团;Ar is an aromatic group;
所述的X为N或CH;Y为取代甲酰基、酯基或膦酰基;Described X is N or CH; Y is substituted formyl, ester group or phosphono group;
所述的A为氨基保护基团;Described A is amino protecting group;
R1选自芳基、芳基乙烯基中的一种;R2选自烷基、苄基中的一种;R 1 is selected from one of aryl and aryl vinyl; R 2 is selected from one of alkyl and benzyl;
所述碱为碳酸铯、1,8-二氮杂双环[5.4.0]十一碳-7-烯(DBU)、1,5-二氮杂双环[4.3.0]壬-5-烯(DBN)中的至少一种。The base is cesium carbonate, 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), 1,5-diazabicyclo[4.3.0]non-5-ene ( at least one of DBN).
本发明技术为全新的机理,基于原位形成的Kukhtin-Ramirez加合物与双官能团化合物中极性氨基的插入反应,并采用两步一锅法合成策略发生分子内环化反应,以中等至较高的收率合成了一系列具有C2季碳中心的吲哚啉衍生物。采用本发明的制备方法以及全新的制备思路,初始原料简便易得,底物适用范围广,反应条件温和。现有技术中需使用α-重氮化物、在过渡金属参与下发生反应,然而重氮化物从商业途径可获得的种类有限,且操作上具有危险性。The technology of the present invention is a completely new mechanism, based on the insertion reaction of the Kukhtin-Ramirez adduct formed in situ with the polar amino group in the bifunctional compound, and the intramolecular cyclization reaction takes place by a two-step one-pot synthesis strategy. A series of indoline derivatives with C2 quaternary carbon centers were synthesized in high yields. By adopting the preparation method and the new preparation idea of the present invention, the initial raw materials are simple and easy to obtain, the substrate is suitable for a wide range, and the reaction conditions are mild. In the prior art, it is necessary to use α-diazides, which are reacted with the participation of transition metals. However, the types of diazides that are commercially available are limited, and the operation is dangerous.
本发明人研究发现,通过所述的底物、并进一步通过所述的六甲基亚磷酰胺以及碱种类的控制,可以出人意料地通过本发明全新机理、一锅、高收率地制备目的产物。The inventors of the present invention have found that the target product can be prepared unexpectedly in a one-pot and high-yield manner through the novel mechanism of the present invention through the control of the substrate and the hexamethylphosphoramidite and the alkali species. .
研究发现,在本发明创新的制备机理下,进一步对底物的Ar取代基、X、Y、R1取代基以及六甲基亚磷酰胺、碱类别的协同控制,可以进一步提升本发明制备机理的优势,可以进一步提升产物的收率。The research found that under the innovative preparation mechanism of the present invention, the further coordinated control of the Ar substituent, X, Y, R 1 substituent of the substrate, hexamethylphosphoramidite, and base types can further improve the preparation mechanism of the present invention. It can further improve the yield of the product.
本发明中,Ar为芳基、杂环芳基或者至少一个芳基与杂环芳基并合形成稠环芳基。优选地,所述的Ar为苯、五元或六元的杂环芳基、由苯环、杂环芳基中的任意两个及以上芳香环并合形成的稠环芳基。杂环芳基的杂原子优选为O、S或N中的至少一种。In the present invention, Ar is an aryl group, a heterocyclic aryl group, or a combination of at least one aryl group and a heterocyclic aryl group to form a fused-ring aryl group. Preferably, the Ar is benzene, a five-membered or six-membered heterocyclic aryl group, a fused-ring aryl group formed by combining any two or more aromatic rings of a benzene ring and a heterocyclic aryl group. The heteroatom of the heterocyclic aryl group is preferably at least one of O, S or N.
Ar中,所述的芳基、杂环芳基或稠环芳基的芳环上允许带有取代基;所述的取代基优选为卤素、硝基、氰基、三氟甲基、C1-C6烷基或C1-C6烷氧基。In Ar, the aromatic ring of the aryl group, heterocyclic aryl group or fused-ring aryl group is allowed to carry a substituent; the substituent is preferably halogen, nitro, cyano, trifluoromethyl, C 1 -C 6 alkyl or C 1 -C 6 alkoxy.
本发明中,当X为N时,Y优选为膦酰基;当X为CH时,Y为取代甲酰基或酯基。所述的取代甲酰基(表达式为-CO-R),优选为烷基取代的甲酰基(R为烷基)、芳基取代的甲酰基(R为芳基),所述的芳基取代的甲酰基例如为苯基甲酰基、取代苯基甲酰基。所述的膦酰基可以是硫杂化的膦酰基。(例如-P(S)RR)。In the present invention, when X is N, Y is preferably a phosphono group; when X is CH, Y is a substituted formyl group or an ester group. The substituted formyl group (expressed as -CO-R) is preferably an alkyl-substituted formyl group (R is an alkyl group), an aryl-substituted formyl group (R is an aryl group), and the aryl-substituted formyl group is The formyl group is, for example, phenylformyl, substituted phenylformyl. The phosphono group may be a thiohybridized phosphono group. (eg -P(S)RR).
本发明人研究发现,X优选为CH,且Y为取代甲酰基。该结构相对于其他类型的双官能团化合物,可以出人意料地提升产物收率。The inventors of the present invention found that X is preferably CH, and Y is a substituted formyl group. This structure can unexpectedly improve product yield relative to other types of bifunctional compounds.
更进一步优选,X为CH,且Y为芳基取代的甲酰基。Even more preferably, X is CH and Y is an aryl-substituted formyl group.
所述的-A可以是行业内所熟知的用于保护氨基的基团,优选为-Ts(对甲苯磺酰基)、-Cbz、-Boc或-Fmoc。The -A can be a group well known in the industry for protecting an amino group, preferably -Ts (p-toluenesulfonyl), -Cbz, -Boc or -Fmoc.
作为优选,所述双官能团化合物包括邻氨基苯甲醛衍生物。Preferably, the bifunctional compound includes an o-aminobenzaldehyde derivative.
进一步优选,所述的双官能团化合物具有式1-A、式1-B或式1-C结构式:Further preferably, the bifunctional compound has the structural formula of formula 1-A, formula 1-B or formula 1-C:
R3~R6独自为氢、卤素、硝基、氰基、三氟甲基、C1-C6烷基、C1-C6烷氧基取代的芳基或杂环芳基中的一种;R 3 to R 6 are independently one of hydrogen, halogen, nitro, cyano, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy substituted aryl or heterocyclic aryl kind;
所述的R7、R8独自为苯基;Said R 7 and R 8 are independently phenyl;
所述的R9为C1-C6烷基、苄基;Described R 9 is C 1 -C 6 alkyl, benzyl;
R10~R14独自为氢、卤素、硝基、氰基、三氟甲基、C1-C6烷基、C1-C6烷氧基取代的芳基或杂环芳基中的一种。R 10 to R 14 are independently one of hydrogen, halogen, nitro, cyano, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy substituted aryl or heterocyclic aryl kind.
本发明人研究发现,采用式1-C结构的化合物,相对于式1-A、式1-B,可以出人意料地提升一锅制备的收率。The inventors of the present invention have found that the compound of formula 1-C can unexpectedly improve the yield of one-pot preparation compared with formula 1-A and formula 1-B.
进一步研究发现,R3优选为H,该位置为吸电子或者供电子基团均一定程度影响产物收率。R4优选为C1-C6烷基时,可以出人意料地提升产物收率。R5可以是H、吸电子基团或者供电子基团。R6优选为H,在该位置设置供电子以及吸电子基团,均一定程度影响产物的收率。Further research found that R 3 is preferably H, and the position of electron withdrawing or electron donating group will affect the yield of the product to a certain extent. When R 4 is preferably a C 1 -C 6 alkyl group, the product yield can be unexpectedly improved. R 5 can be H, an electron withdrawing group or an electron donating group. R 6 is preferably H, and the placement of electron-donating and electron-withdrawing groups at this position affects the yield of the product to a certain extent.
作为优选,R3、R5、R6为氢;R4为C1-C6的烷氧基,进一步优选为甲氧基。Preferably, R 3 , R 5 and R 6 are hydrogen; R 4 is a C 1 -C 6 alkoxy group, more preferably a methoxy group.
研究还发现,R10~R13中,除位于对位的R13为强供电基团时,可以显著提升产物收率。The research also found that, among R 10 to R 13 , except when R 13 located in the para position is a strong power supply group, the product yield can be significantly improved.
作为优选,R10、R11、R13、R14为氢;R12为C1-C6的烷氧基,进一步优选为甲氧基。研究发现,该优选的底物下,可以出人意料地高达92%。Preferably, R 10 , R 11 , R 13 and R 14 are hydrogen; R 12 is a C 1 -C 6 alkoxy group, more preferably a methoxy group. The study found that under this preferred substrate, it can be unexpectedly as high as 92%.
本发明式2的α-羰基甲酸酯包括含有不同取代基的苯甲酰甲酸酯、β,γ-不饱和苯甲酰甲酸酯化合物。The α-carbonyl formate of formula 2 of the present invention includes benzoyl formate and β,γ-unsaturated benzoyl formate compounds containing different substituents.
优选地,所述的R1选自芳基、芳基乙烯基中的一种。Preferably, the R 1 is selected from one of aryl and arylvinyl.
本发明研究还发现,式2化合物中,R1基团选择对产物收率也具有较大影响。作为优选,所述的R1苯基或取代苯基。所述的取代苯基的取代基例如为卤素、硝基、氰基、三氟甲基、C1-C6烷基或C1-C6烷氧基。研究发现,R1优选为苯基或者取代苯基时,可以出人意料地提升产物的收率。It is also found in the research of the present invention that in the compound of formula 2, the choice of R 1 group also has a great influence on the product yield. Preferably, the R 1 phenyl or substituted phenyl. The substituent of the substituted phenyl group is, for example, halogen, nitro, cyano, trifluoromethyl, C 1 -C 6 alkyl or C 1 -C 6 alkoxy. It is found that when R 1 is preferably phenyl or substituted phenyl, the yield of the product can be unexpectedly improved.
R2选自C1-C6烷基或苄基;优选为乙基。R 2 is selected from C 1 -C 6 alkyl or benzyl; preferably ethyl.
进一步优选,R1为苯基、R2为乙基。该优选的底物可以出人意料地进一步提升产物的收率。More preferably, R 1 is phenyl and R 2 is ethyl. This preferred substrate can surprisingly further enhance the yield of the product.
作为优选,α-羰基甲酸酯、双官能团化合物的摩尔比为1:(1~1.5)。Preferably, the molar ratio of the α-carbonyl formate and the bifunctional compound is 1:(1-1.5).
作为优选,α-羰基甲酸酯、六甲基亚磷酰胺的摩尔量的1:(1~1.5)。Preferably, the molar ratio of α-carbonyl formate and hexamethyl phosphoramidite is 1:(1-1.5).
本发明研究发现,采用本发明要求的碱,可以出人意料地成功制备目的产物。It is found in the research of the present invention that the desired product can be prepared unexpectedly and successfully by using the base required by the present invention.
作为优选,所述的碱为碳酸铯。优选的碱可以进一步提升目的产物的收率。Preferably, the base is cesium carbonate. The preferred base can further improve the yield of the target product.
作为优选,碱与α-羰基甲酸酯的摩尔投料比为1:1~2.5:1。Preferably, the molar feeding ratio of the base to the α-carbonyl formate is 1:1 to 2.5:1.
本发明人研究还发现,在对底物、六甲基亚磷酰胺和碱的控制的基础上,进一步控制反应溶剂体系,有助于进一步提升本发明全新机理的制备优势,有助于进一步提升制备效果。The inventors also found that, on the basis of the control of the substrate, hexamethylphosphoramidite and base, further control of the reaction solvent system is helpful to further improve the preparation advantages of the new mechanism of the present invention, and is helpful to further improve Preparation effect.
所述有机溶剂选自乙腈、苯、甲苯、二甲苯、四氢呋喃(THF)、二氧六环、二氯甲烷、氯仿、1,2-二氯乙烷、N,N-二甲基甲酰胺(DMF)、二甲基亚砜(DMSO)中的任意一种或多种。The organic solvent is selected from acetonitrile, benzene, toluene, xylene, tetrahydrofuran (THF), dioxane, dichloromethane, chloroform, 1,2-dichloroethane, N,N-dimethylformamide ( DMF), any one or more of dimethyl sulfoxide (DMSO).
作为优选,所述的有机溶剂为二氯甲烷。研究发现,在该优选的有机溶剂体系下,可以出人意料地进一步提升本发明创新地制备机理的效果,提升目的产物的收率。Preferably, the organic solvent is dichloromethane. The research found that under the preferred organic solvent system, the effect of the innovative preparation mechanism of the present invention can be further improved unexpectedly, and the yield of the target product can be improved.
本发明研究发现,进一步控制制备过程中的温度,有助于进一步提升制备效果。It is found in the research of the present invention that further controlling the temperature in the preparation process is helpful to further improve the preparation effect.
作为优选,在低于0℃下投加六甲基亚磷酰胺,投加完成后升温至室温下反应;室温下反应完成后投加所述的碱;保持在该温度下继续反应至结束。Preferably, hexamethylphosphoramidite is added at a temperature lower than 0° C., and after the addition is completed, the temperature is raised to the room temperature for reaction; the alkali is added after the reaction is completed at room temperature; and the reaction is continued at this temperature until the end.
作为优选,所述的室温为10~40℃。Preferably, the room temperature is 10-40°C.
作为优选,双官能团化合物、α-羰基甲酸酯、六甲基亚磷酰胺在室温下反应时间优选为0.5~2h。Preferably, the reaction time of the bifunctional compound, α-carbonyl formate and hexamethyl phosphoramidite at room temperature is preferably 0.5-2 h.
碱投加完成后继续反应时间为2小时至20小时。After the alkali addition is completed, the reaction time is 2 hours to 20 hours.
进一步优选,本发明制备方法,将α-羰基甲酸酯及双官能团化合物溶于有机溶剂,然后在氮气保护、-78℃温度下将六甲基亚磷酰胺(可预先用所述的反应溶剂稀释)滴加至反应体系中,滴加完毕后置于室温搅拌反应0.5-2小时后,将碱加入反应体系中,再室温下反应2小时至20小时;随后分离、纯化得到目的产物。Further preferably, in the preparation method of the present invention, the α-carbonyl formate and the bifunctional compound are dissolved in an organic solvent, and then hexamethylphosphoramidite (can be used in advance with the reaction solvent under nitrogen protection at a temperature of -78°C) Dilution) is added dropwise to the reaction system, after the dropwise addition is completed, the reaction is stirred at room temperature for 0.5-2 hours, then the base is added to the reaction system, and the reaction is performed at room temperature for 2 hours to 20 hours; then the desired product is obtained by separation and purification.
本发明所述的制备方法,包括一种优选的具有C2季碳中心的吲哚啉衍生物的合成方法(见合成线路B),将式1-A、式1-B或式1-C结构式的反应底物α-羰基甲酸酯及双官能团化合物溶于有机溶剂,然后在氮气保护、-78℃温度下将六甲基亚磷酰胺滴加至反应体系中,上述化合物摩尔投料比为1:(1~1.5):(1~1.5),滴加完毕后将所得反应混合物移出低温反应器,并置于室温搅拌反应2小时。反应完成后,将一定量的碱加入反应体系中,室温下反应2小时至20小时。然后将溶剂在减压下脱除,粗产品经200~300目硅胶柱层析纯化,得具有C2季碳中心的吲哚啉目标化合物(式3-A、式3-B或式3-C)。淋洗剂采用石油醚-乙酸乙酯混合溶剂,体积比为15:1~5:1;以所得纯品计算收率。根据目标化合物的不同,收率可高达92%。目标化合物制备的量和反应容器的体积可按相应比例扩大或缩小。The preparation method of the present invention includes a preferred method for synthesizing an indoline derivative with a C2 quaternary carbon center (see synthesis route B). The reaction substrate α-carbonyl formate and the bifunctional compound are dissolved in an organic solvent, and then hexamethylphosphoramidite is added dropwise to the reaction system under nitrogen protection at a temperature of -78 ° C, and the molar feeding ratio of the above compounds is 1 :(1~1.5):(1~1.5), after the dropwise addition, the obtained reaction mixture was removed from the low-temperature reactor, and was stirred at room temperature for 2 hours. After the reaction is completed, a certain amount of base is added to the reaction system, and the reaction is carried out at room temperature for 2 to 20 hours. Then the solvent is removed under reduced pressure, and the crude product is purified by 200-300 mesh silica gel column chromatography to obtain the indoline target compound (formula 3-A, formula 3-B or formula 3-C) with a C2 quaternary carbon center ). The eluent adopts petroleum ether-ethyl acetate mixed solvent, and the volume ratio is 15:1 to 5:1; the yield is calculated based on the obtained pure product. Depending on the target compound, yields can be as high as 92%. The amount of the target compound prepared and the volume of the reaction vessel can be scaled up or down accordingly.
线路Bline B
有益效果:Beneficial effects:
1、本发明提供了一种全新的制备具有C2季碳中心的吲哚啉衍生物的制备机理;1. The present invention provides a new preparation mechanism for preparing indoline derivatives with C2 quaternary carbon centers;
2、在本发明全新的制备机理下,进一步控制制备过程中的底物取代基、碱和反应溶剂,有助于进一步提升制备效果,提升目的产物收率。2. Under the new preparation mechanism of the present invention, the substrate substituent, base and reaction solvent in the preparation process are further controlled, which helps to further improve the preparation effect and improve the yield of the target product.
3、提供的具有C2季碳中心的吲哚啉衍生物Ι具有潜在生物活性及药理作用;提供的合成方法原料易得、反应条件温和、底物适应性广,且属于全新的合成策略。本发明为该类化合物的合成提供了新方法。3. The provided indoline derivative I with a C2 quaternary carbon center has potential biological activity and pharmacological action; the provided synthetic method has easily available raw materials, mild reaction conditions, wide substrate adaptability, and belongs to a brand-new synthetic strategy. The present invention provides a new method for the synthesis of such compounds.
具体实施方式:Detailed ways:
本发明通过特定制备实施例,更加具体地说明具有C2季碳中心的吲哚啉衍生物Ι的合成方法,所述实施例的用途仅用于具体说明本发明,尤其是具体实施的实验条件仅是举例说明,并非对本发明的实际保护范围构成任何限定。具体实施方式如下:In the present invention, the synthesis method of the indoline derivative I with a C2 quaternary carbon center is described in more detail through specific preparation examples. The purposes of the examples are only used to specifically illustrate the present invention. It is an example, and does not constitute any limitation to the actual protection scope of the present invention. The specific implementation is as follows:
以下实施例中所采用的反应底物ΙΙ为α-羰基甲酸酯,采用已知合成方法制备(参见Zhang,X.,et al.Org.Lett.2015,17,3782;Ayyampillai,M.,et al.TetrahedronLett.2014,55,3503),其结构通式为:The reaction substrate III used in the following examples is α-carbonyl formate, prepared by known synthetic methods (see Zhang, X., et al. Org. Lett. 2015, 17, 3782; Ayyampillai, M., et al.TetrahedronLett.2014,55,3503), its general structural formula is:
所采用的反应底物ΙΙΙ为双官能团化合物,采用已知合成方法制备(参见Huang,Y.,et al.Org.Lett.2009,11,991;Micheline,G.,et al.Tetrahedron Lett.1985,26,53),其结构通式为:The adopted reaction substrate III is a bifunctional compound, prepared by known synthetic methods (see Huang, Y., et al. Org. Lett. 2009, 11, 991; Micheline, G., et al. Tetrahedron Lett. 1985, 26 ,53), and its general structural formula is:
本发明所合成的具有C2季碳中心的吲哚啉衍生物Ι的线路为:The route of the indoline derivative I with C2 quaternary carbon center synthesized by the present invention is:
上述结构通式中:In the above structural formula:
式II中:R1选自苯基、苯基乙烯基中的一种;R2选自C1-C6烷基、苄基中的一种;In formula II: R 1 is selected from a kind of phenyl group and phenylvinyl group; R 2 is selected from a kind of C 1 -C 6 alkyl group and benzyl group;
式III、I中:Ra选自卤素、硝基、氰基、三氟甲基、C1-C6烷基或C1-C6烷氧基的一种;In formula III and I: R a is selected from one of halogen, nitro, cyano, trifluoromethyl, C 1 -C 6 alkyl or C 1 -C 6 alkoxy;
将反应底物α-羰基甲酸酯ΙΙ及双官能团化合物ΙΙΙ溶于有机溶剂,然后在氮气保护、-78℃温度下六甲基亚磷酰胺滴加至反应体系中,上述化合物摩尔投料比为1:(1~1.5):(1~1.5),滴加完毕后将所得反应混合物移出低温反应器,并置于室温搅拌反应2小时。反应完成后,将一定量的碱加入反应体系中,室温下反应2小时至20小时。然后将溶剂在减压下脱除,粗产品经200~300目硅胶柱层析纯化,得目标化合物Ι。淋洗剂采用石油醚-乙酸乙酯混合溶剂,体积比为15:1~5:1;以所得纯品计算收率。The reaction substrate α-carbonyl formate 11 and the bifunctional compound 111 are dissolved in the organic solvent, and then under nitrogen protection, at -78 ° C, hexamethylphosphoramidite is added dropwise to the reaction system, and the above-mentioned compound molar feeding ratio is 1: (1-1.5): (1-1.5), after the dropwise addition, the obtained reaction mixture was removed from the low-temperature reactor, and the reaction mixture was placed at room temperature and stirred for 2 hours. After the reaction is completed, a certain amount of base is added to the reaction system, and the reaction is carried out at room temperature for 2 to 20 hours. Then the solvent was removed under reduced pressure, and the crude product was purified by 200-300 mesh silica gel column chromatography to obtain the target compound I. The eluent adopts petroleum ether-ethyl acetate mixed solvent, and the volume ratio is 15:1 to 5:1; the yield is calculated based on the obtained pure product.
实施例1Example 1
具有C2季碳中心的吲哚啉化合物IP1的合成及结构鉴定,结构通式中(式II和III)中R1=Ph,R2=Et,Ra=H,X=CH,Y=COPh。Synthesis and structural identification of indoline compound IP1 with C2 quaternary carbon center, in the general structural formula (formula II and III), R 1 =Ph, R 2 =Et, R a =H, X=CH, Y=COPh .
在装有磁搅拌子的25mL Schlenk瓶中,依次加入苯甲酰甲酸乙酯(式II中,R1=Ph,R2=Et)36mg(0.2mmol)、邻氨基查尔酮(式III中,Ra=H,X=CH,Y=COPh)83mg(0.22mmol)、1.5mL二氯甲烷,然后在氮气保护、-78℃温度下滴加六甲基亚磷酰胺的二氯甲烷溶液(36mg,溶于0.5mL二氯甲烷)至反应体系中,滴加完毕后将所得反应混合物移出低温反应器,并置于室温搅拌反应2小时。反应完成后,直接将98mg碳酸铯(Cs2CO3,0.30mmol)加入反应体系中,并置于室温下继续反应2小时。反应完成后将溶剂减压脱除,粗产品经200~300目硅胶柱层析纯化,其中淋洗剂采用石油醚-乙酸乙酯混合溶剂,体积比为15:1~5:1,得顺式产物为白色固体纯品47mg,反式产物为白色固体纯品34mg,总收率为75%,cis/trans为1.4:1。目标化合物IP-1制备的量和反应容器的体积可按相应比例扩大或缩小;目标化合物IP-1的理化参数见表1。In a 25mL Schlenk flask equipped with a magnetic stirrer, 36 mg (0.2 mmol) of ethyl benzoylformate (in formula II, R 1 =Ph, R 2 =Et), o-aminochalcone (in formula III) were successively added. , Ra =H, X=CH, Y=COPh) 83 mg (0.22 mmol), 1.5 mL of dichloromethane, then under nitrogen protection, at -78 ℃ temperature, was added dropwise a solution of hexamethylphosphoramide in dichloromethane ( 36 mg, dissolved in 0.5 mL of dichloromethane) into the reaction system, after the dropwise addition was completed, the resulting reaction mixture was removed from the low temperature reactor, and was placed at room temperature for stirring for 2 hours. After the reaction was completed, 98 mg of cesium carbonate (Cs 2 CO 3 , 0.30 mmol) was directly added to the reaction system, and the reaction was continued at room temperature for 2 hours. After the reaction is completed, the solvent is removed under reduced pressure, and the crude product is purified by 200-300 mesh silica gel column chromatography, wherein the eluent is a mixed solvent of petroleum ether-ethyl acetate, and the volume ratio is 15:1-5:1. The formula product is 47 mg of pure white solid, the trans product is 34 mg of pure white solid, the total yield is 75%, and the cis/trans ratio is 1.4:1. The amount of the target compound IP-1 prepared and the volume of the reaction vessel can be expanded or reduced according to the corresponding proportion; the physicochemical parameters of the target compound IP-1 are shown in Table 1.
和实施例1相比,区别仅在于,采用NaOH、Na2CO3、K2CO3、Et3N、咪唑、哌啶、DABCO作为碱时,反应不能获得目的产物。因此,确定所述的底物在六甲基亚磷酰胺参与,Cs2CO3、DBU、DBN作为碱的条件下可以成功实施本发明的全新的制备机理、一锅高收率地制得目的产物。在该基础上,进一步对反应过程中的反应溶剂体系、反应温度进行合理控制,可以进一步提升制得的目的产物的收率。Compared with Example 1, the only difference is that when NaOH, Na 2 CO 3 , K 2 CO 3 , Et 3 N, imidazole, piperidine and DABCO are used as bases, the desired product cannot be obtained in the reaction. Therefore, it is confirmed that the substrate can successfully implement the new preparation mechanism of the present invention under the condition that hexamethylphosphoramidite is involved and Cs 2 CO 3 , DBU, and DBN are used as bases, and the purpose is to be prepared in one pot with high yield. product. On this basis, by further reasonably controlling the reaction solvent system and the reaction temperature in the reaction process, the yield of the obtained target product can be further improved.
实施例2Example 2
具有C2季碳中心的吲哚啉化合物IP-1的合成及结构鉴定,结构通式中(式II和III)中R1=Ph,R2=Et,Ra=H,X=CH,Y=COPh。Synthesis and structural identification of indoline compound IP-1 with C2 quaternary carbon center, in the general structural formula (formula II and III), R 1 =Ph, R 2 =Et, R a =H, X=CH, Y =COPh.
所用原料、合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Raw materials used, synthesis steps and process parameters are basically the same as Example 1, and the differences are listed as follows:
第二步所用碱为DBU,用量为46mg(0.30mmol);得顺式产物为白色固体纯品16mg,反式产物为白色固体纯品34mg,总收率为46%,cis/trans为1:2.1。理化参数见表1。The base used in the second step is DBU, and the consumption is 46mg (0.30mmol); The cis product is 16mg of pure white solid, and the trans product is 34mg of pure white solid, and the total yield is 46%, and cis/trans is 1: 2.1. The physical and chemical parameters are shown in Table 1.
实施例3Example 3
具有C2季碳中心的吲哚啉化合物IP-2的合成及结构鉴定,结构通式中(式II和III)中R1=Ph,R2=Et,Ra=H,X=CH,Y=CO-3-OMe-C6H4(3-甲氧基苯甲酰基)。Synthesis and structural identification of indoline compound IP-2 with C2 quaternary carbon center, in the general structural formula (formula II and III), R 1 =Ph, R 2 =Et, R a =H, X=CH, Y =CO-3-OMe- C6H4 ( 3 -methoxybenzoyl).
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料双官能团化合物ΙΙΙ为邻氨基查尔酮(Y=CO-3-MeO-C6H4),用量为90mg(0.22mmol);得顺式产物为淡黄色固体纯品40mg,反式产物为淡黄色固体纯品24mg,总收率为56%,cis/trans为1.7:1。理化参数见表1。The used raw material bifunctional compound III is o-aminochalcone (Y=CO-3-MeO-C 6 H 4 ), and the consumption is 90 mg (0.22 mmol); the cis product is 40 mg of pure light yellow solid, and the trans product is 40 mg. It is 24 mg of pure light yellow solid, the total yield is 56%, and the cis/trans ratio is 1.7:1. The physical and chemical parameters are shown in Table 1.
实施例4Example 4
具有C2季碳中心的吲哚啉化合物IP-3的合成及结构鉴定,结构通式中(式II和III)中R1=Ph,R2=Et,Ra=H,X=CH,Y=CO-4-Cl-C6H4(4-氯苯甲酰基)。Synthesis and structure identification of indoline compound IP-3 with C2 quaternary carbon center, in the general structural formula (formula II and III), R 1 =Ph, R 2 =Et, R a =H, X=CH, Y =CO-4-Cl- C6H4 ( 4 -chlorobenzoyl).
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料双官能团化合物ΙΙΙ为邻氨基查尔酮(Y=CO-4-Cl-C6H4),用量为91mg(0.22mmol);得顺式产物为淡黄色固体纯品34mg,反式产物为黄色固体纯品31mg,总收率为57%,cis/trans为1.1:1。理化参数见表1。The used raw material bifunctional compound III is o-aminochalcone (Y=CO-4-Cl-C 6 H 4 ), and the consumption is 91 mg (0.22 mmol); the cis product is 34 mg of pure light yellow solid, and the trans product is 34 mg. It was 31 mg of pure yellow solid, the total yield was 57%, and the cis/trans ratio was 1.1:1. The physical and chemical parameters are shown in Table 1.
实施例5Example 5
具有C2季碳中心的吲哚啉化合物IP-4的合成及结构鉴定,结构通式(式II和III)中R1=Ph,R2=Et,Ra=H,X=CH,Y=CO-4-OMe-C6H4(4-甲氧基苯甲酰基)。Synthesis and structural identification of indoline compound IP-4 with C2 quaternary carbon center, R 1 =Ph, R 2 =Et, R a =H, X=CH, Y= CO-4-OMe- C6H4 ( 4 -methoxybenzoyl).
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料双官能团化合物ΙΙΙ为邻氨基查尔酮(Y=CO-4-OMe-C6H4),用量为90mg(0.22mmol);得顺式产物为淡黄色固体纯品42mg,反式产物为淡黄色固体纯品55mg,总收率为85%,cis/trans为1:1.3。理化参数见表1。The raw material bifunctional compound 111 used is o-aminochalcone (Y=CO-4-OMe-C 6 H 4 ), and the consumption is 90 mg (0.22 mmol); the cis product is 42 mg of pure light yellow solid, and the trans product is 42 mg. It is 55 mg of pure light yellow solid, the total yield is 85%, and the cis/trans ratio is 1:1.3. The physical and chemical parameters are shown in Table 1.
实施例6Example 6
具有C2季碳中心的吲哚啉化合物IP-5的合成及结构鉴定,结构通式(式II和III)中R1=Ph,R2=Et,Ra=H,X=CH,Y=CO-4-Me-C6H4(4-甲基苯甲酰基)。Synthesis and structural identification of indoline compound IP-5 with C2 quaternary carbon center, R 1 =Ph, R 2 =Et, R a =H, X=CH, Y= CO-4-Me- C6H4 ( 4 -methylbenzoyl).
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料双官能团化合物ΙΙΙ为邻氨基查尔酮(Y=CO-4-Me-C6H4),用量为86mg(0.22mmol);得顺式产物为黄色固体纯品19mg,反式产物为黄色固体纯品34mg,总收率为48%,cis/trans为1:1.8。理化参数见表1。The used raw material bifunctional compound III is o-aminochalcone (Y=CO-4-Me-C 6 H 4 ), and the consumption is 86 mg (0.22 mmol); the cis product is 19 mg of pure yellow solid, and the trans product is The pure yellow solid was 34 mg, the total yield was 48%, and the cis/trans ratio was 1:1.8. The physical and chemical parameters are shown in Table 1.
实施例7Example 7
具有C2季碳中心的吲哚啉化合物IP-6的合成及结构鉴定,结构通式(式II和III)中R1=Ph,R2=Et,Ra=4-Me,X=CH,Y=COPh(苯甲酰基)。Synthesis and structure identification of indoline compound IP-6 with C2 quaternary carbon center, R 1 =Ph, R 2 =Et, R a =4-Me, X =CH Y=COPh (benzoyl).
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料双官能团化合物ΙΙΙ为邻氨基查尔酮(Ra=4-Me),用量为86mg(0.22mmol);得顺式产物为黄色固体纯品38mg,反式产物为黄色固体纯品20mg,总收率为52%,cis/trans为1.9:1。理化参数见表1。The used raw material bifunctional compound III is o-aminochalcone (R a =4-Me), and the consumption is 86mg (0.22mmol); the cis product is 38mg of pure yellow solid, and the trans product is 20mg of pure yellow solid, The overall yield was 52% with a cis/trans of 1.9:1. The physical and chemical parameters are shown in Table 1.
实施例8Example 8
具有C2季碳中心的吲哚啉化合物IP-7的合成及结构鉴定,结构通式(式II和III)中R1=Ph,R2=Et,Ra=4-OMe,X=CH,Y=COPh。Synthesis and structural identification of indoline compound IP-7 with C2 quaternary carbon center, R 1 =Ph, R 2 =Et, R a =4-OMe, X=CH in the general structural formula (formula II and III), Y=COPh.
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料双官能团化合物ΙΙΙ为邻氨基查尔酮(Ra=4-OMe),用量为90mg(0.22mmol);得顺式产物为淡黄色固体纯品55mg,反式产物为白色固体纯品50mg,总收率为92%,cis/trans为1.1:1。理化参数见表1。The used raw material bifunctional compound III is o-aminochalcone (R a =4-OMe), and the consumption is 90 mg (0.22 mmol); the cis product is 55 mg of pure light yellow solid, and the trans product is 50 mg of pure white solid , the overall yield was 92%, and the cis/trans ratio was 1.1:1. The physical and chemical parameters are shown in Table 1.
实施例9Example 9
具有C2季碳中心的吲哚啉化合物IP-8的合成及结构鉴定,结构通式(式II和III)中R1=Ph,R2=Et,Ra=4-Cl,X=CH,Y=COPh。Synthesis and structure identification of indoline compound IP-8 with C2 quaternary carbon center, R 1 =Ph, R 2 =Et, R a =4-Cl, X =CH in the general structural formula (formula II and III), Y=COPh.
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料双官能团化合物ΙΙΙ为邻氨基查尔酮(Ra=4-Cl),用量为91mg(0.22mmol);得顺式产物为橘黄色固体纯品50mg,反式产物为淡黄色固体纯品28mg,总收率为68%,cis/trans为1.8:1。理化参数见表1。The raw material bifunctional compound 111 used is o-aminochalcone (R a =4-Cl), and the consumption is 91mg (0.22mmol); the cis product is a pure orange solid product 50mg, and the trans product is a pure light yellow solid product 28 mg, 68% overall yield, 1.8:1 cis/trans. The physical and chemical parameters are shown in Table 1.
实施例10Example 10
具有C2季碳中心的吲哚啉化合物IP-9的合成及结构鉴定,结构通式(式II和III)中R1=Ph,R2=Et,Ra=4-CF3,X=CH,Y=COPh。Synthesis and structural identification of indoline compound IP-9 with C2 quaternary carbon center, R 1 =Ph, R 2 =Et, R a =4-CF 3 , X=CH in the general structural formula (formula II and III) , Y=COPh.
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料双官能团化合物ΙΙΙ为邻氨基查尔酮(Ra=4-CF3),用量为98mg(0.22mmol);得顺式产物为白色固体纯品57mg,反式产物为黄色固体纯品28mg,总收率为70%,cis/trans为2:1。理化参数见表1。The used raw material bifunctional compound III is o-aminochalcone (R a =4-CF 3 ), and the consumption is 98mg (0.22mmol); the cis product is 57mg of pure white solid, and the trans product is 28mg of pure yellow solid , the overall yield was 70%, and the cis/trans ratio was 2:1. The physical and chemical parameters are shown in Table 1.
实施例11Example 11
具有C2季碳中心的吲哚啉化合物IP-10的合成及结构鉴定,结构通式(式II和III)中R1=Ph,R2=Et,Ra=5-Cl,X=CH,Y=COPh。Synthesis and structure identification of indoline compound IP-10 with C2 quaternary carbon center, R 1 =Ph, R 2 =Et, R a =5-Cl, X = CH in the general structural formula (formula II and III), Y=COPh.
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料双官能团化合物ΙΙΙ为邻氨基查尔酮(Ra=5-Cl),用量为91mg(0.22mmol);得顺式产物为淡黄色固体纯品53mg,反式产物为淡黄色固体纯品31mg,总收率为74%,cis/trans为1.7:1。理化参数见表1。The used raw material bifunctional compound III is o-aminochalcone (R a =5-Cl), and the consumption is 91 mg (0.22 mmol); the cis product is 53 mg of light yellow solid pure product, and the trans product is light yellow solid pure product 31 mg, 74% overall yield, cis/trans 1.7:1. The physical and chemical parameters are shown in Table 1.
实施例12Example 12
具有C2季碳中心的吲哚啉化合物IP-11的合成及结构鉴定,结构通式(式II和III)中R1=Ph,R2=Et,Ra=5-Br,X=CH,Y=COPh。Synthesis and structure identification of indoline compound IP-11 with C2 quaternary carbon center, R 1 =Ph, R 2 =Et, R a =5-Br, X = CH, Y=COPh.
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料双官能团化合物ΙΙΙ为邻氨基查尔酮(Ra=5-Br),用量为100mg(0.22mmol);得顺式产物为淡黄色固体纯品59mg,反式产物为淡黄色固体纯品42mg,总收率为82%,cis/trans为1.4:1。理化参数见表1。The raw material bifunctional compound III1 used is o-aminochalcone (R a =5-Br), and the consumption is 100mg (0.22mmol); the cis product is 59mg of pure light yellow solid, and the trans product is pure light yellow solid 42 mg, 82% overall yield, 1.4:1 cis/trans. The physical and chemical parameters are shown in Table 1.
实施例13Example 13
具有C2季碳中心的吲哚啉化合物IP-12的合成及结构鉴定,结构通式(式II和III)中R1=Ph,R2=Et,Ra=6-Cl,X=CH,Y=COPh。Synthesis and structural identification of indoline compound IP-12 with C2 quaternary carbon center, R 1 =Ph, R 2 =Et, R a =6-Cl, X=CH in the general structural formula (formula II and III), Y=COPh.
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料双官能团化合物ΙΙΙ为邻氨基查尔酮(Ra=6-Cl),用量为91mg(0.22mmol);得顺式产物为淡黄色固体纯品22mg,反式产物为淡黄色固体纯品47mg,总收率为60%,cis/trans为1:2.1。理化参数见表1。The used raw material bifunctional compound III is o-aminochalcone (R a =6-Cl), and the consumption is 91mg (0.22mmol); the cis product is 22mg of pure light yellow solid, and the trans product is pure light yellow solid 47 mg, 60% overall yield, cis/trans 1:2.1. The physical and chemical parameters are shown in Table 1.
实施例14Example 14
具有C2季碳中心的吲哚啉化合物IP-13的合成及结构鉴定,结构通式(式II和III)中R1=Ph,R2=Et,Ra=H,X=CH,Y=CO2Et。Synthesis and structure identification of indoline compound IP-13 with C2 quaternary carbon center, in the general structural formula (formula II and III), R 1 =Ph, R 2 =Et, R a =H, X=CH, Y= CO 2 Et.
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料双官能团化合物ΙΙΙ为邻氨基苯甲醛衍生物(Ra=H,X=CH,Y=CO2Et),用量为76mg(0.22mmol);得顺式产物为白色固体纯品26mg,反式产物为白色固体纯品23mg,总收率为48%,cis/trans为1.1:1。理化参数见表1。The used raw material bifunctional compound III is an o-aminobenzaldehyde derivative (R a =H, X=CH, Y=CO 2 Et), and the consumption is 76 mg (0.22 mmol); the cis product is 26 mg of pure white solid, and the reverse The product of formula is 23 mg of pure white solid, the total yield is 48%, and the cis/trans ratio is 1.1:1. The physical and chemical parameters are shown in Table 1.
实施例15Example 15
具有C2季碳中心的吲哚啉化合物IP-14的合成及结构鉴定,结构通式(式II和III)中R1=Ph,R2=Et,Ra=H,X=N,Y=-P(S)Ph2。Synthesis and structure identification of indoline compound IP-14 with C2 quaternary carbon center, R 1 =Ph, R 2 =Et, R a =H, X=N, Y= -P(S) Ph2 .
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料双官能团化合物ΙΙΙ为邻氨基苯甲醛衍生物(Ra=H,X=N,Y=P(S)Ph2),用量为108mg(0.22mmol);得单一反式产物为淡黄色固体纯品57mg,收率为44%。理化参数见表1。The used raw material bifunctional compound III is an o-aminobenzaldehyde derivative (R a =H, X=N, Y=P(S)Ph 2 ), and the consumption is 108 mg (0.22 mmol); the single trans product is a pale yellow solid The pure product was 57 mg, and the yield was 44%. The physical and chemical parameters are shown in Table 1.
实施例16Example 16
具有C2季碳中心的吲哚啉化合物IP-15的合成及结构鉴定,结构通式(式II和III)中R1=—CH=CHPh,R2=Et,Ra=H,X=CH,Y=COPh。Synthesis and structure identification of indoline compound IP-15 with C2 quaternary carbon center, R 1 =—CH=CHPh, R 2 =Et, R a =H, X=CH in the general structural formula (formula II and III) , Y=COPh.
合成步骤及工艺参数与实施例1基本相同,不同之处列出如下:Synthesis step and process parameter are basically identical with embodiment 1, and difference is listed as follows:
所用原料α-羰基甲酸酯ΙΙ为苯乙烯基甲酰甲酸乙酯(R1=—CH=CHPh,R2=Et),用量为41mg(0.20mmol);所用原料双官能团化合物ΙΙΙ为邻氨基查尔酮(Ra=H,X=CH,Y=COPh),用量为91mg(0.22mmol);第二步所用碱为DBU,用量为46mg(0.30mmol);得顺式产物为淡黄色油状液体纯品13mg,反式产物为淡黄色油状液体纯品23mg,总收率为32%,cis/trans为1:1.8。理化参数见表1。The raw material α-carbonyl formate III used is ethyl styryl formate (R 1 =—CH=CHPh, R 2 =Et), and the consumption is 41 mg (0.20 mmol); the raw material bifunctional compound III is an o-amino group Chalcone (R a =H, X=CH, Y=COPh), the dosage is 91mg (0.22mmol); the base used in the second step is DBU, the dosage is 46mg (0.30mmol); the cis product is a pale yellow oily The liquid pure product is 13 mg, and the trans product is 23 mg of light yellow oily liquid pure product. The total yield is 32%, and the cis/trans ratio is 1:1.8. The physical and chemical parameters are shown in Table 1.
表1.本发明的具有C2季碳中心的吲哚啉衍生物Ι的化学结构和理化参数Table 1. The chemical structure and physicochemical parameters of the indoline derivative I with C2 quaternary carbon center of the present invention
本发明通过所述的底物以及六甲基亚磷酰胺和所述的碱的作用下,可以基于原位形成的Kukhtin-Ramirez加合物一锅法合成目的产物,且通过采用优选底物、配合制备条件,可以获得高达92%的收率。In the present invention, the target product can be synthesized by one-pot method based on the Kukhtin-Ramirez adduct formed in situ under the action of the substrate, hexamethylphosphoramidite and the base, and by adopting the preferred substrate, With the preparation conditions, a yield as high as 92% can be obtained.
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910223550.2A CN109776388B (en) | 2019-03-22 | 2019-03-22 | Synthetic method of indoline derivative with C2 quaternary carbon center |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910223550.2A CN109776388B (en) | 2019-03-22 | 2019-03-22 | Synthetic method of indoline derivative with C2 quaternary carbon center |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109776388A CN109776388A (en) | 2019-05-21 |
CN109776388B true CN109776388B (en) | 2020-10-27 |
Family
ID=66490397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910223550.2A Active CN109776388B (en) | 2019-03-22 | 2019-03-22 | Synthetic method of indoline derivative with C2 quaternary carbon center |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109776388B (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5338755A (en) * | 1990-07-31 | 1994-08-16 | Elf Sanofi | N-sulfonylindoline derivatives, their preparation and the pharmaceutical compositions in which they are present |
-
2019
- 2019-03-22 CN CN201910223550.2A patent/CN109776388B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN109776388A (en) | 2019-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2019346118B2 (en) | Manufacture of compounds and compositions for inhibiting the activity of SHP2 | |
CN105175327B (en) | A kind of synthetic method of quinoline | |
CN108409746A (en) | A kind of chiral oxo spiro indole class compound and its raceme and preparation method containing pyrroles or indoles and azacycloalkyl structure | |
CN108997215B (en) | Preparation method of 1,2,3, 4-tetrahydroisoquinoline derivative | |
CN108658841B (en) | Carbazole compound and preparation method thereof | |
CN111423394B (en) | Synthesis method of 1,3, 4-oxadiazole heterocyclic compound | |
CN115197153A (en) | Preparation method of 1,4-diazacycloalkane compound | |
WO2024031753A1 (en) | Indoline compound and preparation method therefor | |
CN108148021A (en) | 2- imines (3H) furane derivative or thiophene derivant and its synthesis | |
CN109776388B (en) | Synthetic method of indoline derivative with C2 quaternary carbon center | |
CN105820174B (en) | A kind of preparation method of polysubstituted thiophene diindyl derivative | |
CN107098902B (en) | A kind of synthetic method of pyrrolo[1,2-a]quinoline derivative | |
CN114874139B (en) | A kind of synthesis method of 1-benzyl or allyl 3,4-dihydroisoquinoline | |
KR101001129B1 (en) | Method for preparing dibenzoxepine derivative | |
CN109776465B (en) | A kind of synthetic method of chromanthane derivative with C2 quaternary carbon center | |
CN111018800B (en) | A kind of N2-aryl substituted-1,2,4-triazine derivative and its synthesis and application | |
CN110776510B (en) | Preparation method of 1- (2-quinolyl) -beta-carboline natural product and derivative | |
CN107868087A (en) | A kind of method for preparing pyrrolo-indole analog derivative | |
CN115785104A (en) | A kind of synthesis method of spiro[indoline-3,3'-pyrrolidine] derivatives catalyzed by monovalent gold | |
CN105272953A (en) | Method for synthesizing coumarone naphthoquinone derivative | |
CN106467481B (en) | The synthetic method of indoles -3- aryl ketone derivatives | |
CN106083649B (en) | A kind of synthetic method of the Cyclohexadiene derivatives of 3,5 diaryl, 2,6,6 tricyano, 1 imino group 2,4 | |
CN101691356A (en) | Method for synthesizing Baylis-Hillman addition compound containing 5-chloropyrazolo rings | |
CN110526855A (en) | A kind of preparation method for the indole derivatives that 3- nitroso replaces | |
CN105693594B (en) | A kind of synthetic method of tetrahydro cyclopentyl alkane and azole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |